BSE Live
May 29, 16:00Prev. Close
301.05
Open Price
293.00
Bid Price (Qty.)
298.00 (220)
Offer Price (Qty.)
301.05 (375)
NSE Live
Sep 21, 11:08Prev. Close
301.20
Open Price
350.00
Bid Price (Qty.)
343.05 (125)
Offer Price (Qty.)
349.00 (100)
| Key Financial Ratios of Dishman Pharmaceuticals & Chemicals (in Rs. Cr.) | Mar 11 | Mar 10 | Mar 09 | Mar 08 | Mar 07 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 4.97 | 8.81 | 11.42 | 7.04 | 7.21 | |
| Diluted EPS (Rs.) | 4.97 | 8.81 | 11.42 | 7.04 | 7.21 | |
| Cash EPS (Rs.) | 8.44 | 11.37 | 13.87 | 9.16 | 9.18 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 79.27 | 75.68 | 68.04 | 56.73 | 37.09 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 79.48 | 75.90 | 68.26 | 56.95 | 37.33 | |
| Dividend / Share(Rs.) | 1.20 | 1.20 | 1.20 | 1.00 | 1.00 | |
| Revenue from Operations/Share (Rs.) | 52.15 | 43.69 | 51.52 | 45.05 | 38.73 | |
| PBDIT/Share (Rs.) | 14.51 | 15.64 | 17.57 | 12.45 | 11.74 | |
| PBIT/Share (Rs.) | 11.04 | 13.08 | 15.12 | 10.34 | 9.77 | |
| PBT/Share (Rs.) | 6.01 | 9.84 | 11.78 | 9.11 | 8.97 | |
| Net Profit/Share (Rs.) | 4.97 | 8.81 | 11.42 | 7.04 | 7.21 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 27.82 | 35.79 | 34.10 | 27.62 | 30.32 | |
| PBIT Margin (%) | 21.16 | 29.93 | 29.34 | 22.94 | 25.22 | |
| PBT Margin (%) | 11.53 | 22.52 | 22.86 | 20.22 | 23.16 | |
| Net Profit Margin (%) | 9.53 | 20.15 | 22.16 | 15.63 | 18.60 | |
| Return on Networth / Equity (%) | 6.27 | 11.63 | 16.78 | 12.41 | 19.43 | |
| Return on Capital Employed (%) | 3.93 | 7.21 | 12.14 | 8.59 | 9.92 | |
| Return on Assets (%) | 2.81 | 6.02 | 9.80 | 6.80 | 7.44 | |
| Total Debt/Equity (X) | 0.76 | 0.71 | 0.53 | 0.58 | 1.11 | |
| Asset Turnover Ratio (%) | 29.57 | 29.86 | 44.21 | 43.49 | 40.03 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.78 | 1.92 | 1.87 | 1.89 | 1.72 | |
| Quick Ratio (X) | 0.47 | 1.41 | 1.23 | 1.19 | 1.16 | |
| Inventory Turnover Ratio (X) | 3.39 | 3.53 | 3.57 | 2.98 | 2.84 | |
| Dividend Payout Ratio (NP) (%) | 24.13 | 13.62 | 10.50 | 14.37 | 14.04 | |
| Dividend Payout Ratio (CP) (%) | 14.21 | 10.55 | 8.65 | 11.06 | 11.02 | |
| Earnings Retention Ratio (%) | 75.87 | 86.38 | 89.50 | 85.63 | 85.96 | |
| Cash Earnings Retention Ratio (%) | 85.79 | 89.45 | 91.35 | 88.94 | 88.98 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,306.54 | 2,144.19 | 1,104.78 | 2,556.90 | 1,825.13 | |
| EV/Net Operating Revenue (X) | 3.10 | 6.08 | 2.66 | 7.12 | 6.53 | |
| EV/EBITDA (X) | 11.16 | 16.99 | 7.79 | 25.78 | 21.52 | |
| MarketCap/Net Operating Revenue (X) | 1.95 | 4.86 | 1.97 | 6.40 | 5.48 | |
| Retention Ratios (%) | 75.86 | 86.37 | 89.49 | 85.62 | 85.95 | |
| Price/BV (X) | 1.29 | 2.81 | 1.49 | 5.09 | 5.72 | |
| Price/Net Operating Revenue | 1.95 | 4.86 | 1.97 | 6.40 | 5.48 | |
| Earnings Yield | 0.05 | 0.04 | 0.11 | 0.02 | 0.03 |